Abstract
Rare pentoses, especially L-rare pentoses, have been attracting increasing attention because of their medicinal applications in antiviral and anticancer therapy, where they are used to produce L-nucleoside analogues. To address the problems of low natural abundance and limited synthetic methods for rare pentoses, biological synthesis has emerged recently as promising routes to these valuable compounds. This review summarizes enzymatic synthesis and whole cell microbial transformations of seven rare pentoses (L-ribulose, L-ribose, Lxylulose, L-xylose, L-lyxose, D-lyxose, D-xylulose) and two sugar alcohols (xylitol, L-arabinitol) as well as their interconversions. Examples of improving existing enzymes and discovering new systems are also discussed as advancements in genomics and bioengineering.
Keywords: Rare sugars, pentose, biosynthesis, microorganism, enzyme.
Graphical Abstract
Current Organic Chemistry
Title:Synthesis of Rare Pentoses Using Microbial and Enzymatic Reactions
Volume: 20 Issue: 14
Author(s): Zijie Li, Xiao-Dong Gao and Li Cai
Affiliation:
Keywords: Rare sugars, pentose, biosynthesis, microorganism, enzyme.
Abstract: Rare pentoses, especially L-rare pentoses, have been attracting increasing attention because of their medicinal applications in antiviral and anticancer therapy, where they are used to produce L-nucleoside analogues. To address the problems of low natural abundance and limited synthetic methods for rare pentoses, biological synthesis has emerged recently as promising routes to these valuable compounds. This review summarizes enzymatic synthesis and whole cell microbial transformations of seven rare pentoses (L-ribulose, L-ribose, Lxylulose, L-xylose, L-lyxose, D-lyxose, D-xylulose) and two sugar alcohols (xylitol, L-arabinitol) as well as their interconversions. Examples of improving existing enzymes and discovering new systems are also discussed as advancements in genomics and bioengineering.
Export Options
About this article
Cite this article as:
Li Zijie, Gao Xiao-Dong and Cai Li, Synthesis of Rare Pentoses Using Microbial and Enzymatic Reactions, Current Organic Chemistry 2016; 20 (14) . https://dx.doi.org/10.2174/1385272820666151207190715
DOI https://dx.doi.org/10.2174/1385272820666151207190715 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Seek of Neuroprotection: Introducing Cannabinoids
Recent Patents on CNS Drug Discovery (Discontinued) Methionine Aminopeptidases as Potential Targets for Treatment of Gastrointestinal Cancers and other Tumors
Current Drug Targets The Heme Oxygenase/Biliverdin Reductase Pathway in Drug Research and Development
Current Drug Metabolism IBD Modern Concepts, Nano Drug Delivery and Patents: An Update
Recent Patents on Nanomedicine The Application of Mass Spectrometry to Proteomics and Metabolomics in Biomarker Discovery and Drug Development
Current Molecular Pharmacology Gap Junction Synthesis and Degradation as Therapeutic Targets
Current Drug Targets Editorial (Hot Topic: Foods versus Drugs in Disease Prevention and Treatment)
Current Pediatric Reviews <i>Taraxacum officinale</i> Extracts Exhibit Safe and Selective Anticancer Activity
The Natural Products Journal DTCM-glutarimide Delays Growth and Radiosensitizes Glioblastoma
Anti-Cancer Agents in Medicinal Chemistry Sex Impact on Biomarkers, Pharmacokinetics and Pharmacodynamics
Current Medicinal Chemistry Follow the ATP: Tumor Energy Production: A Perspective
Anti-Cancer Agents in Medicinal Chemistry Chronic Immune Stimulation Correlates with Reduced Phenylalanine Turnover
Current Drug Metabolism Entrectinib: A New Selective Tyrosine Kinase Inhibitor Approved for the Treatment of Pediatric and Adult Patients with NTRK Fusionpositive, Recurrent or Advanced Solid Tumors
Current Medicinal Chemistry Successfully Resuscitated Sudden Cardiac Death in a Young Homosexual Male with HIV Myocarditis
Current HIV Research Review on Chemogenomics Approach: Interpreting Antagonist Activity of Secreted Frizzled-Related Protein 1 in Glaucoma Disease with In-Silico Docking
Current Topics in Medicinal Chemistry Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery How to Manage the Infectious Risk under Anti-TNF in Inflammatory Bowel Disease
Current Drug Targets An Overview of the Modulatory Effects of Oleic Acid in Health and Disease
Mini-Reviews in Medicinal Chemistry Tumor Necrosis Factor Inhibitors in Pediatric Asthma
Recent Patents on Inflammation & Allergy Drug Discovery Understanding the Role of Corona Virus based on Current Scientific Evidence - A Review with Emerging Importance in Pandemic
Recent Patents on Anti-Infective Drug Discovery